LUC- University Centre

Diepenbeek 3590

0 studies enrolling now · 1 studies all time

What they study most

Multiple Sclerosis, Relapsing-Remitting

Studies at this site

• Safety and Efficacy of Natalizumab in the Treatment of Multiple Sclerosis — Completed